Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid
AssigneeSeikagaku Corporation
InventorsEiji NOGAMI, Akira KOUSHINBOU, Noriko OSHIMA, Kota FUJIWARA, Tomoya SATO
Life of this patent
Estimating the term…
Abstract
The present invention relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, and a pharmaceutically acceptable carrier, and which can be stored at room temperature. The present invention also relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, sorbitol, and a pharmaceutical acceptable carrier.
Claims8
1-20. (canceled)
A method for stabilizing an aqueous composition, wherein the method comprising adding sorbitol in an aqueous composition which comprises 20 to 60 mg/mL of chondroitin sulfate, 10 to 40 mg/mL of hyaluronic acid, and a pharmaceutically acceptable carrier, thereby stabilizing the aqueous composition at room temperature.
A method of manufacturing an ophthalmic surgical aid, comprising including an aqueous composition in an ophthalmic surgical aid employed in an ophthalmic surgery for treating an ocular disease, wherein the aqueous composition comprises chondroitin sulfate, hyaluronic acid, sorbitol, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.